Pièce de transition, 24/29, 14/23, 1 pièce

5-Methoxy-1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine, 95.0%, 1g

(S)-2-ETHYNYLPYRROLIDINE HCL, 95.0%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)toluene, 98.0%, 1g

Chlorure de magnésium hexahydraté, min 99%, pa, ACS, 1 kg, emballage plastique.

2-Amino-3-methyl-3-phenylbutanoic acid hydrochloride, 98%, 250mg

6-Methyl-1,2,3,4-tetrahydroquinoxaline, 98%, 250mg

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-(4-methyltrityl)-L-lysine>98.0%(HPLC)(N)5g

Bis(2-((4R,5R)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)phenyl)amine, 98% +99%ee, 1g

Benzyl (2,2-dimethoxyethyl)(methyl)carbamate, 95%, 250mg

Cyclohexyltrimethoxysilane, 97%, 100g

(2,6-Dichloropyridin-4-yl)boronic acid, 95.0%, 25g

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 100mg